Different effects of whole-cell and acellular vaccines on Bordetella transmission

Journal of Infectious Diseases

Volumn 209, Issue 12, 2014, Pages 1981-1988

  Smallridge, William E ^a   Rolin, Olivier Y ^a   Jacobs, Nathan T ^a   Harvill, Eric T ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Bordetella; Transmission; Vaccination

Indexed keywords

ACELLULAR VACCINE; BACTERIAL VACCINE; BORDETELLA BRONCHISEPTICA VACCINE; BORDETELLA VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; PERTUSSIS VACCINE; UNCLASSIFIED DRUG; VIRUS ANTIBODY; WHOLE CELL VACCINE;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; BACTERIAL TRANSMISSION; BORDETELLA BRONCHISEPTICA; BORDETELLA BRONCHISEPTICA INFECTION; BORDETELLA PERTUSSIS; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DIPHTHERIA; DRUG EFFECT; HOST PATHOGEN INTERACTION; IMMUNE RESPONSE; INFECTION CONTROL; LYMPHOCYTE MIGRATION; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PERTUSSIS; PRIORITY JOURNAL; SHAM PROCEDURE; T CELL DEPLETION; TETANUS; VACCINATION; VIRUS SHEDDING;

BORDETELLA; TRANSMISSION; VACCINATION;

ANIMALS; B-LYMPHOCYTES; BACTERIAL VACCINES; BORDETELLA BRONCHISEPTICA; BORDETELLA INFECTIONS; BORDETELLA PERTUSSIS; CD4 LYMPHOCYTE COUNT; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, TRANSGENIC; VACCINATION; VACCINES, ACELLULAR;

EID: 84901780916     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu030     Document Type: Article

References (37)

1. Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 2005; 18:326-82. (Pubitemid 40548297)
2. Cherry JD. Pertussis: challenges today and for the future. PLoS Pathog 2013; 9:e1003418.
3. Allen A. Public health. The pertussis paradox. Science 2013; 341:454-5.
4. Crowcroft NS, Stein C, Duclos P, Birmingham M. How best to estimate the global burden of pertussis? Lancet Infect Dis 2003; 3:413-8. (Pubitemid 36791118)
5. Crowcroft NS, Booy R, Harrison T, et al. Severe and unrecognised: pertussis in UK infants. Arch Dis Child 2003; 88:802-6. (Pubitemid 37094238)
6. Guris D, Strebel PM, Bardenheier B, et al. Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996. Clin Infect Dis 1999; 28:1230-7. (Pubitemid 29272795)
7. de Greeff SC, de Melker HE, van Gageldonk PG, et al. Seroprevalence of pertussis in The Netherlands: evidence for increased circulation of Bordetella pertussis. PLoS One 2010; 5:e14183.
8. Hellenbrand W, Beier D, Jensen E, et al. The epidemiology of pertussis in Germany: past and present. BMC Infect Dis 2009; 9:22.
9. Quinn HE, McIntyre PB. Pertussis epidemiology in Australia over the decade 1995-2005-trends by region and age group. Commun Dis Intell Q Rep 2007; 31:205-15.
10. Higgs R, Higgins SC, Ross PJ, Mills KH. Immunity to the respiratory pathogen Bordetella pertussis. Mucosal Immunol 2012; 5:485-500.
11. Barbic J, Leef MF, Burns DL, Shahin RD. Role of gamma interferon in natural clearance of Bordetella pertussis infection. Infect Immun 1997; 65:4904-8. (Pubitemid 27513528)
12. Ryan M, Murphy G, Ryan E, et al. Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children. Immunology 1998; 93:1-10. (Pubitemid 28133089)
13. Warfel JM, Merkel TJ. Bordetella pertussis infection induces a mucosal IL-17 response and long-lived Th17 and Th1 immune memory cells in nonhuman primates. Mucosal Immunol 2012; 6:787-96.
14. de la Torre MJ, de la Fuente CG, de Alegria CR, Del Molino CP, Aguero JMartinez-Martinez L. Recurrent respiratory infection caused by Bordetella bronchiseptica in an immunocompetent infant. Pediatr Infect Dis J 2012; 31:981-3.
15. Rolin O, Smallridge W, Henry M, Goodfield L, Place D, Harvill E. Tolllike receptor 4 limits transmission of Bordetella bronchiseptica. PLoS One 2014; 9:e85229. doi:10.1371/journal.pone.0085229.
16. Cotter PA, Miller JF. BvgAS-mediated signal transduction: analysis of phase-locked regulatory mutants of Bordetella bronchiseptica in a rabbit model. Infect Immun 1994; 62:3381-90. (Pubitemid 24232124)
17. Stibitz S, Yang MS. Subcellular localization and immunological detection of proteins encoded by the vir locus of Bordetella pertussis. J Bacteriol 1991; 173:4288-96.
18. Dialynas DP, Wilde DB, Marrack P, et al. Characterization of the murine antigenic determinant, designated L3T4a, recognized by monoclonal antibody GK1.5:expression of L3T4a by functional T cell clones appears to correlate primarily with class II MHC antigen-reactivity. Immunol Rev 1983; 74:29-56. (Pubitemid 13050835)
19. Goebel EM, Zhang X, Harvill ET. Bordetella pertussis infection or vaccination substantially protects mice against B. bronchiseptica infection. PLoS One 2009; 4:e6778.
20. Rolin O, Muse SJ, Safi C, et al. Enzymatic modification of the lipid A by an ArnT protects B. bronchiseptica against cationic peptides and is required for transmission. Infect Immun 2013; 82:491-9.
21. Gangarosa EJ, Galazka AM, Wolfe CR, et al. Impact of anti-vaccine movements on pertussis control: the untold story. Lancet 1998; 351:356-61. (Pubitemid 28052710)
22. Lavine J, Bjørnstad O, de Blasio B, Storsaeter J. Short-lived immunity against pertussis, age-specific routes of transmission, and the utility of a teenage booster vaccine. Vaccine 2012; 30:544-51.
23. Lavine J, Broutin H, Harvill E, Bjørnstad O. Imperfect vaccine-induced immunity and whooping cough transmission to infants. Vaccine 2010; 29:11-6.
24. Sheridan SL, Ware RS, Grimwood K, Lambert SB. Number and order of whole cell pertussis vaccines in infancy and disease protection. JAMA 2012; 308:454-6.
25. Auger KA, Patrick SW, Davis MM. Infant hospitalizations for pertussis before and after Tdap recommendations for adolescents. Pediatrics 2013; 132:e1149-55.
26. Warfel JM, Beren J, Merkel TJ. Airborne transmission of Bordetella pertussis. J Infect Dis 2012; 206:902-6.
27. Ross PJ, Sutton CE, Higgins S, et al. Relative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: towards the rational design of an improved acellular pertussis vaccine. PLoS Pathog 2013; 9:e1003264.
28. Torre D, Ferrario G, Bonetta G, Perversi L, Tambini R, Speranza F. Effects of recombinant human gamma interferon on intracellular survival of Bordetella pertussis in human phagocytic cells. FEMS Immunol Med Microbiol 1994; 9:183-8. (Pubitemid 24294324)
29. Ryan EJ, Nilsson L, Kjellman N, Gothefors L, Mills KH. Booster immunization of children with an acellular pertussis vaccine enhances Th2 cytokine production and serum IgE responses against pertussis toxin but not against common allergens. Clin Exp Immunol 2000; 121:193-200. (Pubitemid 30659755)
30. Warfel JM, Zimmerman LI, Merkel TJ. Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model. Proc Natl Acad Sci U S A 2013; 111:787-92.
31. Winter SE, Thiennimitr P, Winter MG, et al. Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature 2010; 467:426-9.
32. Pathak A, Creppage K, Werner J, Cattadori I. Immune regulation of a chronic bacteria infection and consequences for pathogen transmission. BMC Microbiol 2010; 10:226.
33. Wickham M, Brown N, Boyle E, Coombes B, Finlay B. Virulence is positively selected by transmission success between mammalian hosts. Curr Biol 2007; 17:783-8. (Pubitemid 46635120)
34. Gopinath S, Hotson A, Johns J, Nolan G, Monack D. The systemic immune state of super-shedder mice is characterized by a unique neutrophil-dependent blunting of TH1 responses. PLoS Pathog 2013; 9:e1003408.
35. Kirimanjeswara GS, Mann PB, Harvill ET. Role of antibodies in immunity to Bordetella infections. Infect Immun 2003; 71:1719-24. (Pubitemid 36368699)
36. Russell MW, Reinholdt J, Kilian M. Anti-inflammatory activity of human IgA antibodies and their Fab alpha fragments: inhibition of IgG-mediated complement activation. Eur J Immunol 1989; 19:2243-9. (Pubitemid 20024748)
37. van der Neut Kolfschoten M, Schuurman J, Losen M, et al. Antiinflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange. Science 2007; 317:1554-7. (Pubitemid 47417435)